ginsenoside rh2 has been researched along with dinoprostone in 2 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, WY; Lim, CJ; Lim, HW | 1 |
| Chen, F; Deng, ZY; Hong, H; Hu, QR; Huang, QX; Li, J; Luo, T; Pan, Y | 1 |
2 other study(ies) available for ginsenoside rh2 and dinoprostone
| Article | Year |
|---|---|
Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Dinoprostone; Ginsenosides; Humans; Keratinocytes; Lipopolysaccharides; Macrophages; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Nitric Oxide; Reactive Oxygen Species | 2013 |
Ginsenoside Rh2 and its octyl ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the c-Jun/COX2/PGE2 pathway.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Esters; Ginsenosides; Liver Neoplasms; Mice | 2023 |